This inventor holds 1 USPTO granted patent. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Fuminobu Egami: Innovator in Liposome Eye Drops
Introduction
Fuminobu Egami is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on liposome eye drops. His dedication to improving eye care has led to the development of a unique product that addresses various ocular issues.
Latest Patents
Fuminobu Egami holds a patent for liposome eye drops, which is a groundbreaking advancement in the delivery of medication to the eyes. This invention aims to enhance the effectiveness and comfort of eye treatments, providing patients with a more efficient solution for their eye care needs. He has 1 patent to his name.
Career Highlights
Egami is currently employed at Taisho Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His work at Taisho has allowed him to focus on research and development, contributing to the company's reputation for innovation in healthcare products.
Collaborations
Throughout his career, Fuminobu Egami has collaborated with talented individuals such as Kenji Tsunoda and Tomohiro Ohtsuki. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of new technologies.
Conclusion
Fuminobu Egami's contributions to the field of pharmaceuticals, particularly through his patent for liposome eye drops, highlight his commitment to advancing eye care solutions. His work at Taisho Pharmaceutical Co., Ltd. and collaborations with esteemed colleagues further emphasize his role as an innovator in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
